Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-133.85%Cash Return on Invested Capital
VS
Market
Sector
Industry
History
$ 0.45Close
$ 0.37 - $ 2.16 52-Week Range
Ticker Information
Ticker
TOVXCompany Name
THERIVA BIOLOGICS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTTHERIVA BIOLOGICS INC - Cash Return on Invested Capital Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TOVX - CROIC Historical data
| Date | Cash Return on Invested Capital | Free Cash Flow | Invested Capital |
|---|---|---|---|
| 6/30/2025 | -133.85% | $ -18.09M | $ 13.51M |
| 3/31/2025 | -91.61% | $ -16.81M | $ 18.35M |
| 12/31/2024 | -82.1% | $ -16.94M | $ 20.63M |
| 9/30/2024 | -71.45% | $ -18.84M | $ 26.37M |
| 6/30/2024 | -64.96% | $ -18.01M | $ 27.73M |
| 3/31/2024 | -55.26% | $ -18.46M | $ 33.41M |
| 12/31/2023 | -49.08% | $ -19.2M | $ 39.12M |
| 9/30/2023 | -41.64% | $ -18.06M | $ 43.37M |
| 6/30/2023 | -41.04% | $ -19.45M | $ 47.38M |
| 3/31/2023 | -39.58% | $ -19.91M | $ 50.32M |
Key Performance Insights, Last 5 Years
- THERIVA BIOLOGICS INC's latest trailing twelve months (TTM) CROIC stands at 0%.
- Over the past 5 years, THERIVA BIOLOGICS INC's average CROIC has been -47.06%.
- The median CROIC for THERIVA BIOLOGICS INC during this period was -40.31%
- THERIVA BIOLOGICS INC reached its highest CROIC over the past 5 years at -13.2%.
- The lowest CROIC recorded by THERIVA BIOLOGICS INC in the same timeframe -133.85%
Similar metrics to Inv. Capital:
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
- Invested Capital - [Calculation] Invested Capital is the total amount of money raised by a business in the form [Equity] and/or [Debt].
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Capital Expenditures Margin - [Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
Definition of Cash Return on Invested Capital
[Calculation] Cash Return on Invested Capital (CROIC) measures how well a company uses its invested capital to produce cash. It is calculated as Free Cash Flow [FCF] divided by invested capital [InvCapital].FCF / Inv. Capital
(=) CROIC CROIC for THERIVA BIOLOGICS INC is calculated as follows: FCF [ $ -12.64M ] / Inv. Capital [ $ -5.51M ]
(=) CROIC [ 0% ] TOVX - Cash Return on Invested Capital, Last 5 years
-133.85%
Minimum
Jun 30, 2025
-13.2%
Maximum
Mar 31, 2021
-47.06%
Average
-40.31%
Median
CROIC Benchmark AnalysisMarket
The chart above depicts the distribution of CROIC for companies in the Total Stock Market. The average CROIC of the companies is 2.84% with a standard deviation of 15.02%.
The following table provides additional summary stats:
CROIC in the Market:
| filtered constituents | 3.46K |
|---|---|
| min | -43.78% |
| max | 49.57% |
| average | 2.84% |
| median | 5.02% |
| std | 15.02% |